Cite
HARVARD Citation
Mahévas, T. et al. (2019). Dramatic response to brentuximab vedotin in refractory nontransformed CD30– mycosis fungoides allowing allogeneic stem cell transplant and long‐term complete remission. British journal of dermatology. pp. 1517-1520. [Online].